← Back to Search

Videoconferencing Smoking Cessation Program for Smoking

N/A
Recruiting
Led By Stephanie L Marhefka, PhD
Research Sponsored by University of South Florida
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
greater than or equal to age 18 (as NRT is not FDA approved for adolescents)
greater than or equal to age 18 (as NRT is not FDA approved for adolescents)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up study day 360
Awards & highlights

Study Summary

This trial is testing whether a smoking cessation program delivered over videoconferencing is more effective than a control program for people with certain chronic conditions.

Who is the study for?
The Positively Quit Trial is for adults over 18 living in the US with certain chronic conditions who smoke cigarettes and are motivated to quit. Participants must have internet access, be able to use Zoom, speak English, and not be pregnant or breastfeeding. They cannot be using other tobacco treatments.Check my eligibility
What is being tested?
This study tests a smoking cessation program delivered via videoconferencing against an Attention Matched Control condition that doesn't focus on quitting but has equal contact hours. Both groups get nicotine patches and advice to quit across 12 sessions.See study design
What are the potential side effects?
Possible side effects may include those associated with nicotine replacement therapy such as skin irritation from patches, dizziness, racing heartbeat, sleep problems or unusual dreams.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.
Select...
I am 18 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~study day 360
This trial's timeline: 3 weeks for screening, Varies for treatment, and study day 360 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Biochemically confirmed 30-day point prevalence abstinence (BC30ppa) day 360
Biochemically confirmed 7-day point prevalence abstinence (BC7ppa) day 360
Biochemically confirmed sustained abstinence (BC.SA) day 360
Secondary outcome measures
Biochemically confirmed 30-day point prevalence abstinence (BC30ppa) day 180
Biochemically confirmed 30-day point prevalence abstinence (BC30ppa) days 90
Biochemically confirmed 7-day point prevalence abstinence (BC7ppa) day 180
+5 more

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Positively MeExperimental Treatment1 Intervention
Positively Me is a 12-session (8 [1.5] hour main sessions plus four booster sessions) intervention guided by Social Cognitive Theory to promote smoking cessation in people with certain health conditions.
Group II: Positively LivingPlacebo Group1 Intervention
Positively Living is a modified updated version of a healthy living intervention based on Social Cognitive Theory that is designed for people with certain health conditions and attention-matched to the experimental condition (8 [1.5] hour main sessions plus four booster sessions).

Find a Location

Who is running the clinical trial?

University of South FloridaLead Sponsor
400 Previous Clinical Trials
184,637 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,584 Previous Clinical Trials
41,239,636 Total Patients Enrolled
Stephanie L Marhefka, PhDPrincipal InvestigatorUniversity of South Florida College of Nursing

Media Library

Positively Living Clinical Trial Eligibility Overview. Trial Name: NCT04449458 — N/A
Smoking/Cigarette Smoking Research Study Groups: Positively Living, Positively Me
Smoking/Cigarette Smoking Clinical Trial 2023: Positively Living Highlights & Side Effects. Trial Name: NCT04449458 — N/A
Positively Living 2023 Treatment Timeline for Medical Study. Trial Name: NCT04449458 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many subjects have signed up to participate in this clinical research?

"Affirmative, the clinicaltrials.gov website confirms that this medical trial is actively seeking volunteers. The initial launch was on June 10th 2020 and it has recently been updated on August 8th 2022. This study requires 482 participants at two different sites of research."

Answered by AI

Are there any current enrollment opportunities for this research?

"Affirmative. Clinicaltrials.gov attests that patient recruitment for this research study, which was initially posted on June 10th 2020, is currently in progress. 482 participants are needed from 2 trial locations."

Answered by AI

What is the principal motivation behind this investigation?

"This clinical study's primary objective is to established biochemical confirmed sustained abstinence (BC.SA) on day 360, while secondary goals comprise of assessing self-efficacy for abstaining from smoking on day 90 via the Smoking: Self-Efficacy/Temptation Short Form (Velicor et al., 1990), biochemically confirming 7 and 30 days point prevalence abstinence respectively on days 42 and 90 using cotinine swab tests with levels less than 10ng/ml indicating successful adherence."

Answered by AI

Who else is applying?

What portion of applicants met pre-screening criteria?
Did not meet criteria

Why did patients apply to this trial?

~134 spots leftby Jul 2025